07/04/2026
Share:
📃 The USP <788> chapter “Particulate Matter in Injections” is evolving and will become officially applicable on August 1, 2026.
Following updates published in July 2025, this chapter introduces important clarifications and progressive changes (USP-PF).
🎯 A key challenge : adapting analytical methods to complex matrices
One of the main challenges of this regulatory evolution is improving the management of particle analysis, particularly in complex matrices.
🔍 Focus on oily suspensions
These types of matrices may create significant analytical constraints, including :
These parameters can make Method 1 (Light Obscuration) unsuitable. In such situations, Method 2 (Microscopy) may become necessary, provided its use is supported by a robust and well-documented scientific rationale.
⚙️ Anticipating USP <788> requirements : a structured approach
To effectively address these new expectations, it is essential to :
This approach helps anticipate regulatory constraints while ensuring reliable results.
🤝 At CEBIPHAR, we provide :
Anticipating these expectations is now essential to secure your development and control strategies.
📩 Our teams are available to discuss your challenges and projects, contact us !